Skip to main content
Egyptian Liver Journal

Table 3 Comparison between baseline and post-treatment different laboratory parameters and FIB-4 in both naive and relapse group of patients

From: Assessment of serum Resistin in detecting Insulin Resistance and their impact on response to direct acting antiviral in chronic viral hepatitis C patients

  

Naive

   

Relapser

 
  

Before ttt

After ttt

P-value

Before ttt

After ttt

P-value

TLC(×103/μL)

Mean ±SD

7.005±2.173

6.512±1.99

0.45

6.470±2.682

5.7±2.44

0.48

HB(g/dL)

Mean ±SD

10.450±0.774

10.1± 0.764

0.85

13.110±1.922

11.5±1.877

0.56

PLT(×103/μL)

Mean ±SD

139.8±57.430

126±55.41

0.51

216.60±65.303

203.5±63.32

0.54

ALT(IU/L)

Mean ±SD

39.200±18.574

40.5± 19.44

0.89

40.50±40.565

41.4± 41.57

0.87

AST(IU/L)

Mean ±SD

39.750± 17.302

40.74 ±17.23

0.92

34.150± 19.288

32.132± 20.22

0.78

Albumin(g/dL)

Mean ±SD

3.605± 0.373

3.51± 0.31

0.83

3.775 ±0.236

3.665± 0.231

0.89

T bilirubin (mg/dL)

Mean ±SD

0.925± 0.510

0.956 ±0.523

0.88

0.840 ±0.357

0.81± 0.345

0.9

INR

Mean ±SD

1.173± 0.208

1.21± 0.213

0.56

1.015 ±0.158

1.055± 0.167

0.7

Fib4

<1.45

7

8

0.41

15

16

0.52

 

>1.45

13

12

 

5

4

 
  1. This table shows no statistical significant difference between baseline and post-treatment different laboratory parameters and FIB-4 in both naive and relapse group of patients
Back to article page